title: 3-d image analysis of fluorescent drug binding.
abstract: Fluorescent ligands provide the means of studying receptors in whole tissues using confocal laser scanning microscopy and have advantages over antibody- or non-fluorescence-based method. Confocal microscopy provides large volumes of images to be measured. Histogram analysis of 3-D image volumes is proposed as a method of graphically displaying large amounts of volumetric image data to be quickly analyzed and compared. The fluorescent ligand BODIFY FL-prazosin (QAPB) was used in mouse aorta. Histogram analysis reports the amount of ligand-receptor binding under different conditions and the technique is sensitive enough to detect changes in receptor availability after antagonist incubation or generic manipulations. QAPB binding was concentration dependent, causing concentration-related rightward shifts in histogram. In the presence of 10 microM phenoxybenzamine (blocking agent), the QAPB (50 nM) histogram overlaps the autofluorescence curve. The histogram obtained for the 1D knockout aorta lay to the left of that control and 1B knockout aorta, indicating a reduction in 1D receptors. We have shown, for the first time, that it is possible to graphically display binding of a fluorescent drug to a biological tissue. Although our application is specific to adrenergic receptors, the general method could be applied to any volumetric, fluorescence-image-based assay.
authors.affiliation: Universidad de Valencia, Valencia, Spain.
authors.forename: M Raquel
authors.initials: MR
authors.lastname: Miquel
authors.forename: Venessa
authors.initials: V
authors.lastname: Segura
authors.forename: Z
authors.initials: Z
authors.lastname: Ali
authors.forename: M P
authors.initials: MP
authors.lastname: D'Ocon
authors.forename: J C
authors.initials: JC
authors.lastname: McGrath
authors.forename: Craig J
authors.initials: CJ
authors.lastname: Daly
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000032:analysis / Q000378:metabolism; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001896:Boron Compounds / Q000032:analysis / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D005456:Fluorescent Dyes / Q000032:analysis* / Q000378:metabolism; D021621:Imaging, Three-Dimensional / Q000379:methods; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D018613:Microscopy, Confocal / Q000379:methods*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011224:Prazosin / Q000032:analysis / Q000737:chemistry / Q000378:metabolism*; D018340:Receptors, Adrenergic, alpha-1 / Q000235:genetics / Q000276:immunology / Q000378:metabolism
chemical_list: C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D000317:Adrenergic alpha-Antagonists; D000906:Antibodies; D001896:Boron Compounds; D005456:Fluorescent Dyes; D018340:Receptors, Adrenergic, alpha-1; D010643:Phenoxybenzamine; D011224:Prazosin